Table 1.
Baseline demographic, clinical and laboratorial characteristics in HIV/Leprosy patients and Leprosy patient.
| BT | RR | BT/HIV | RR/HIV | |
|---|---|---|---|---|
| Total (n) | 6 | 5 | 4 | 8 |
| Age (Year) and median(IQR) | 61 (47–65) | 34 (30–41) | 50 (38–64) | 37 (34–43) |
| Gender, n (%) | ||||
| Male | 2 (33) | 3 (60) | 2 (50) | 6 (75) |
| Female | 4 (67) | 2 (40) | 2 (50) | 2 (25) |
| Ethnicity, n (%) | ||||
| Caucasian | 4 (67) | 2 (40) | 1 (25) | 4 (50) |
| Black | 0 (-) | 2 (40) | 2 (50) | 3 (37) |
| Mestizo | 2 (33) | 1 (20) | 1 (25) | 1 (13) |
| Mitsuda test (%) | ||||
| Positive | 40 | 60 | 100 | 70 |
| Negative | 60 | 40 | - | 30 |
| CD4+ T cell, median (IQR) | - | - | 201 (129–228) | 364 (118–483) |
| Viral load median (IQR, copies/mL) | - | - | 7,053(79–21,000) | 1,653 (79–5,700) |
N, number of cases; IQR, interquartile range.